KALPALATHA GUNTUPALLI to Nitric Oxide Synthase
This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Nitric Oxide Synthase.
Connection Strength
0.124
-
Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med. 2004 Jan; 32(1):13-20.
Score: 0.051
-
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med. 1999 May; 27(5):913-22.
Score: 0.037
-
Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Clin Pharmacol Ther. 1999 Jan; 65(1):1-9.
Score: 0.036